Overview

A Drug Interaction Study of ACH-0145228

Status:
Completed
Trial end date:
2020-04-16
Target enrollment:
Participant gender:
Summary
This was a 2-part study (Part 1 and Part 2), with each part being an open-label, fixed sequence, 2-period study in healthy adult participants.
Phase:
Phase 1
Details
Lead Sponsor:
Alexion Pharmaceuticals
Collaborators:
Achillion, a wholly owned subsidiary of Alexion
Celerion
Treatments:
Digoxin
Itraconazole
Midazolam